- 17kAccesses
- 309Citations
- 28Altmetric
- 1Mention
Metrics
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses
Last updated: Wed, 30 Sep 2026 15:44:25 UTC
Accesses
Accesses is an approximate count of unique views and downloads. This number can fluctuate depending on multiple factors.
We update counts daily.
17k Accesses
Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
309Citations
Altmetric
- 6 tweeters
- 1 news outlets
- 2 F1000
- 1 Video uploaders
- 168 Mendeley
Altmetric calculates a score based on the online attention an article gets — the higher the score, the more online attention an article has received.
The donut visual summarises attention from different sources such as social media and news outlets. A breakdown is shown in the legend.
Older articles have had more time to get noticed, so Altmetric provides context data for articles of a similar age.
This article is in the 92nd percentile (ranked 26,266th) of the 358,652 tracked articles of a similar age in all journals and the 94th percentile (ranked 1st) of the 19 tracked articles of a similar age in Journal of Hematology & Oncology.
View more on Altmetric.
This list highlights individual mainstream news articles and blogs that cite the article.
Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media.
Altmetric are responsible for the curation of this list and provide updates hourly.